Respironics ( RESP - NASDAQ ) has just reported the last Q results . Part of RESPIRONICS biz is actually the second leg in the DUOPOLY of RMD/RESP in the APNEA sleep disorder market . Key drivers for the Company's domestic revenue performance include a year-over-year increase of 15 percent in domestic sleep therapy products. Let's hope RMD did the same . First call consensus expected increase for RMD is 12% in EPS growth .It is expected to report EPS USc 28 for the Q and USD 1.06 for the FY , Duff
- Forums
- ASX - By Stock
- RMD
- RMD - A possible profit clue
RMD - A possible profit clue
Add RMD (ASX) to my watchlist
|
|||||
Last
$27.55 |
Change
-0.360(1.29%) |
Mkt cap ! $43.78B |
Open | High | Low | Value | Volume |
$27.48 | $27.57 | $27.37 | $37.40M | 1.357M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 226 | $27.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$27.56 | 215 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 395 | 27.540 |
11 | 598 | 27.530 |
4 | 705 | 27.520 |
5 | 810 | 27.510 |
5 | 498 | 27.500 |
Price($) | Vol. | No. |
---|---|---|
27.560 | 367 | 4 |
27.570 | 403 | 5 |
27.580 | 684 | 2 |
27.590 | 684 | 2 |
27.600 | 984 | 3 |
Last trade - 11.10am 19/05/2022 (20 minute delay) ? |
|
|||||
Last
$27.62 |
  |
Change
-0.360 ( 0.90 %) |
|||
Open | High | Low | Volume | ||
$27.43 | $27.63 | $27.37 | 24316 | ||
Last updated 11.28am 19/05/2022 (live) ? |
RMD (ASX) Chart |